These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29541486)
1. Primary intracerebral INI1-deficient rhabdoid tumor with CD34 immunopositivity in a young adult. Bodi I; Giamouriadis A; Sibtain N; Laxton R; King A; Vergani F Surg Neurol Int; 2018; 9():45. PubMed ID: 29541486 [TBL] [Abstract][Full Text] [Related]
2. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor. Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041 [TBL] [Abstract][Full Text] [Related]
3. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum. Yin X; Yang X; Wang S; Zhou J; Zhao M Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617 [TBL] [Abstract][Full Text] [Related]
4. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928 [TBL] [Abstract][Full Text] [Related]
5. A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1. Rekhi B; Thomas A Pathologica; 2021 Dec; 113(6):456-462. PubMed ID: 34974552 [TBL] [Abstract][Full Text] [Related]
6. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review. Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693 [TBL] [Abstract][Full Text] [Related]
7. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917 [TBL] [Abstract][Full Text] [Related]
8. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature]. Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751 [No Abstract] [Full Text] [Related]
9. CNS Low-grade Diffusely Infiltrative Tumors With INI1 Deficiency, Possessing a High Propensity to Progress to Secondary INI1-deficient Rhabdoid Tumors. Nobusawa S; Nakata S; Nakano Y; Kawamura A; Yoshida M; Tamura A; Hasegawa D; Kosaka Y; Ito I; Watanabe R; Oishi T; Hayashi N; Ishikawa E; Sakamoto N; Okura N; Murakami C; Ichimura K; Hirato J; Yokoo H Am J Surg Pathol; 2020 Nov; 44(11):1459-1468. PubMed ID: 33045149 [TBL] [Abstract][Full Text] [Related]
10. Fulminant presentation of a SMARCB1-deficient, anterior cranial fossa tumor in adult. Levitan I; Fichman S; Laviv Y Surg Neurol Int; 2020; 11():195. PubMed ID: 32754366 [TBL] [Abstract][Full Text] [Related]
11. Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Kohashi K; Oda Y Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176 [TBL] [Abstract][Full Text] [Related]
12. Meningeal SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily B member 1 (SMARCB1)-deficient tumours: an emerging group of meningeal tumours. Dadone B; Fontaine D; Mondot L; Cristofari G; Jouvet A; Godfraind C; Varlet P; Ranchère-Vince D; Coindre JM; Gastaud L; Baudoin C; Peyron AC; Thyss A; Coutts M; Michiels JF; Pedeutour F; Burel-Vandenbos F; Neuropathol Appl Neurobiol; 2017 Aug; 43(5):433-449. PubMed ID: 27732747 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089 [TBL] [Abstract][Full Text] [Related]
14. Atypical teratoid rhabdoid tumor (AT/RT) in adults: review of four cases. Makuria AT; Rushing EJ; McGrail KM; Hartmann DP; Azumi N; Ozdemirli M J Neurooncol; 2008 Jul; 88(3):321-30. PubMed ID: 18369529 [TBL] [Abstract][Full Text] [Related]
15. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor. Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347 [TBL] [Abstract][Full Text] [Related]
16. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Agaimy A Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309 [TBL] [Abstract][Full Text] [Related]
17. A Pediatric Intra-Axial Malignant SMARCB1-Deficient Desmoplastic Tumor Arising in Meningioangiomatosis. Rossi S; Brenca M; Zanatta L; Trincia E; Guerriero A; Pizzato C; Fiorindi A; Viscardi E; Giangaspero F; Maestro R; Dei Tos AP; Giannini C J Neuropathol Exp Neurol; 2018 Oct; 77(10):883-889. PubMed ID: 30169623 [TBL] [Abstract][Full Text] [Related]
18. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report. Fujita K; Mizuguchi K; Mori T; Shimoda T; Sakano K; Shimaguchi C; Ito A; Yoshimura K; Sakaguchi M; Imi T; Ikeda H Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580 [TBL] [Abstract][Full Text] [Related]
19. SMARCB1 (INI1) retained but SMARCA4 (BRG1) negative atypical teratoid/rhabdoid tumor arising at the bilateral cerebellopontine angles: a case report. Mitsui N; Oikawa K; Tanino M; Kinoshita M J Surg Case Rep; 2021 Sep; 2021(9):rjab400. PubMed ID: 34611487 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization. Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]